Freedom of Information Request 0156 2019/20
I am writing to you today to request the following information regarding Cancer Treatments at your organisation.
- Does your trust treat adult multiple myeloma [MM] ? – if you refer your multiple myeloma patients to another centre, please state which.
- If yes, then how many MM patients, have been treated in the past 6 months with the following;
- Bortezomib [Velcade]
- Carfilzomib [Kyprolis]
- Ixazomib [Ninlaro]
- Lenalidomide [Revlimid]
- Daratumumab [Darzalex]
- Melphalan, prednisolone and thalidomide (known as MPT)
- Cyclophosphamide, thalidomide and dexamethasone (known as CTD)
- Pomalidomide [Imnovid]
- If you are able to split by therapy line for question 2, please indicate the number of patients above being treated, 1st line and 2nd line.
- Does your trust treat adult/paediatric primary immune thrombocytopenia patients [ITP] ? – if you refer your adult/paediatric primary immune thrombocytopenia patients to another centre, please state which.
- If yes, then of the treated adult/paediatric primary immune thrombocytopenia patients, how many are on the following;
- Eltrombopag [Revolade]
- Romiplostim [Nplate]
- At what line of treatment would you currently use a Thrombopoietin Receptor Agonist [TPO] (Eltrombopag [Revolade], Romiplostim [Nplate]) in an immune thrombocytopenia purpura [ITP] patient.
- 1st
- 2nd
- 3rd
- 4th
- Unknown
- Do you treat patients with a Thrombopoietin Receptor Agonist TPO for the following diseases?
7a. Chronic hepatitis C virus (HCV) infection for the treatment of thrombocytopenia, where the degree of thrombocytopenia is the main factor preventing the initiation or limiting the ability to maintain optimal interferon-based therapy
- Eltrombopag [Revolade]
- Romiplostim [Nplate]
7b.Acquired severe aplastic anaemia (SAA) who were either refractory to prior immunosuppressive therapy or heavily pre-treated and are unsuitable for haematopoietic stem cell transplantation
- Eltrombopag [Revolade]
- Romiplostim [Nplate]
7c. Chemotherapy induced thrombocytopenia (CIT)
- Eltrombopag [Revolade]
- Romiplostim [Nplate]
- 7d myelodysplastic syndromes (MDS)
- Eltrombopag [Revolade]
- Romiplostim [Nplate]
- Over the past 6 months [latest possible], how many chronic lymphocytic leukaemia (CLL) patients have you treated?
- If possible how many CLL patients treated were new to therapy in the past 3 months?
- How many chronic lymphocytic leukaemia patients, have been treated in the past 6 months with the following;
- Fludarabine (Fludara), cyclophosphamide (Cytoxan), and rituximab (known as FCR)
- Bendamustine and rituximab (known as BR)
- Ibrutinib [Imbruvica]
- Chlorambucil
- Venetoclax
- Obinutuzumab
- Idelalisib
- Fludarabine and rituximab (known as FR)
- High-dose prednisone and rituximab
- Pentostatin (Nipent), cyclophosphamide, and rituximab (known as PCR)
- Alemtuzumab (Campath) with rituximab
Please see attached document
